Location History:
- Sandwich, GB (2003)
- Cambridge, GB (2004 - 2005)
- Kent, GB (2005)
- East Lyme, CT (US) (2021 - 2023)
Company Filing History:
4 out of 2,538 
3 out of 4,455 
1 out of 1 Years Active: 2003-2023
Title: The Innovator Behind Pharmaceutical Breakthroughs: David Clive Blakemore
Introduction:
David Clive Blakemore is a visionary inventor based in Cambridge, GB, who has made significant contributions to the field of pharmaceuticals. With a remarkable total of 8 patents under his name, Blakemore is recognized for his groundbreaking work in developing phosphodiesterase 4 (PDE4) inhibitors to treat various diseases and disorders.
Latest Patents:
Blakemore's recent patents include the development of Substituted 1,2-oxaborolan-2-ols as potent PDE4 inhibitors. These boron-containing compounds have shown promise in inhibiting PDE4, leading to the creation of pharmaceutical compositions for the treatment of conditions ameliorated by PDE4 inhibition. Additionally, his invention of the PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol, including its crystalline monohydrate form, further showcases his innovation in the pharmaceutical industry.
Career Highlights:
Blakemore has honed his expertise while working at prestigious companies such as Warner-Lambert Company and Pfizer Corporation. These experiences have undoubtedly influenced his innovative approach to drug discovery and development, leading to the creation of novel pharmaceutical solutions that have the potential to impact countless lives.
Collaborations:
Throughout his career, Blakemore has collaborated with skilled professionals in the field, including Justin Stephen Bryans and Sophie Caroline Williams. Together, they have leveraged their collective expertise to drive forward advancements in pharmaceutical research and development, culminating in the creation of groundbreaking treatments that address unmet medical needs.
Conclusion:
David Clive Blakemore's relentless pursuit of innovation and his commitment to advancing pharmaceutical science have solidified his position as a pioneering inventor in the industry. His latest patents stand as a testament to his visionary approach and dedication to improving healthcare through the development of novel therapeutic solutions.